Lipoprotein atherogenicity: an overview of current mechanisms

作者: Bruce A. Griffin

DOI: 10.1079/PNS19990022

关键词:

摘要: Raised serum cholesterol does not adequately explain the increased risk of CHD within populations or relationship between diet and CHD. Nevertheless, principal transport vehicle in circulation, LDL, must still be regarded as most atherogenic lipoprotein species, but because its contribution to cholesterol. The potential LDL majority individuals arises from an increase number small dense particles content per se. There is now a wealth evidence cross-sectional prospective studies show that particle size significantly associated with predictive coronary risk. Moreover, there are credible mechanisms link process. rate influx lipoproteins into arterial wall function size, will thus more rapid for LDL. Components extracellular tissue matrix intima, notably proteoglycans, selectively bind high affinity, sequestering this pro-oxidative environment. oxidation promotes final deposition wall, numerous have shown susceptible oxidative modification than larger lighter counterparts. An may originate defect metabolism triacylglycerol-rich lipoproteins. One mechanism involve overproduction residence time large VLDL postprandial phase, situation thought arise through pathways insulin resistance.

参考文章(35)
Jean-Pierre Desp??rs, Andr?? Marette, Relation of components of insulin resistance syndrome to coronary disease risk. Current Opinion in Lipidology. ,vol. 5, pp. 274- 289 ,(1994) , 10.1097/00041433-199408000-00006
A. Keys, Coronary heart disease in seven countries. Circulation. ,vol. 41, pp. 186- 195 ,(1970)
F Nigon, P Lesnik, M Rouis, MJ Chapman, Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor Journal of Lipid Research. ,vol. 32, pp. 1741- 1753 ,(1991) , 10.1016/S0022-2275(20)41629-3
Daniel Steinberg, Lipoproteins and Atherogenesis JAMA. ,vol. 264, pp. 3047- 3052 ,(1990) , 10.1001/JAMA.1990.03450230083034
Jeffrey M. Hoeg, Lipoproteins and atherogenesis. Endocrinology and Metabolism Clinics of North America. ,vol. 27, pp. 569- 584 ,(1998) , 10.1016/S0889-8529(05)70026-8
Bruce A. Griffin, Dilys J. Freeman, Graeme W. Tait, Jim Thomson, Muriel J. Caslake, Christopher J. Packard, James Shepherd, Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk Atherosclerosis. ,vol. 106, pp. 241- 253 ,(1994) , 10.1016/0021-9150(94)90129-5
B??rge G. Nordestgaard, Lars B. Nielsen, Atherosclerosis and arterial influx of lipoproteins Current Opinion in Lipidology. ,vol. 5, pp. 252- 257 ,(1994) , 10.1097/00041433-199408000-00002
Melissa A Austin, Jan L Breslow, Charles H Hennekens, Julie E Buring, Walter C Willett, Ronald M Krauss, Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction JAMA: The Journal of the American Medical Association. ,vol. 260, pp. 1917- 1921 ,(1988) , 10.1001/JAMA.1988.03410130125037
A. Sniderman, S. Shapiro, D. Marpole, B. Skinner, B. Teng, P. O. Kwiterovich, Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 77, pp. 604- 608 ,(1980) , 10.1073/PNAS.77.1.604
B. Strisower, V. Herring, T. P. Lyon, J. W. Gofman, F. Lindgren, H. Elliott, W. Mantz, J. Hewitt, The role of lipids and lipoproteins in atherosclerosis. Science. ,vol. 111, pp. 166- 186 ,(1950) , 10.1126/SCIENCE.111.2877.166